Aberrant DNA methylation of phosphodiestarase 4D alters airway smooth muscle cell phenotypes

Amanda H Y Lin, Yan Shang, Wayne A Mitzner, James Sham, Wan-Yee Tang

Research output: Contribution to journalArticle

Abstract

Airway hyperresponsiveness (AHR) is a hallmark feature in asthma characterized by exaggerated airway contractile response to stimuli due to increased airway sensitivity and chronic airway remodeling. We have previously shown that allergen-induced AHR in mice is associated with aberrant DNA methylation in the lung genome, suggesting that AHR could be epigenetically regulated, and these changes might predispose the animals to asthma. Previous studies demonstrated that overexpression of phosphodiesterase 4D (PDE4D) is associated with increased AHR. However, epigenetic regulation of this gene in asthmatic airway smooth muscle cells (ASMCs) has not been examined. In this study, we aimed to examine the relationship between epigenetic regulation of PDE4D and ASMC phenotypes. We identified CpG site-specific hypomethylation at PDE4D promoter in human asthmatic ASMCs. We next used methylated oligonucleotides to introduce CpG site-specific methylation at PDE4D promoter and examined its effect on ASMCs. We showed that PDE4D methylation decreased cell proliferation and migration of asthmatic ASMCs. We further elucidated that methylated PDE4D decreased PDE4D expression in asthmatic ASMCs, increased cAMP level, and inhibited the aberrant increase in Ca2+ level. Moreover, PDE4D methylation reduced the phosphorylation level of downstream effectors of Ca signaling, including myosin light chain kinase and p38. Taken together, our findings demonstrate that gene-specific epigenetic changes may predispose ASMCs to asthma through alterations in cell phenotypes. Modulation of ASMC phenotypes by methylated PDE4D oligonucleotides can reverse the aberrant ASMC functions to normal phenotypes. This has provided new insight to the development of novel therapeutic options for this debilitative disease.

Original languageEnglish (US)
Pages (from-to)241-249
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume54
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Type 4 Cyclic Nucleotide Phosphodiesterase
DNA Methylation
Smooth Muscle Myocytes
Muscle
Cells
Phenotype
Epigenomics
Methylation
Asthma
Oligonucleotides
Airway Remodeling
Myosin-Light-Chain Kinase
Genes
Allergens
Cell Movement
Phosphorylation
Cell Proliferation
Genome

Keywords

  • Airway hyperresponsiveness
  • Airway smooth muscle cell
  • DNA methylation
  • Methylated DNA oligonucleotides
  • Phosphodiesterase 4D

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

@article{086d288f3d254fab97f38d3ee646a62e,
title = "Aberrant DNA methylation of phosphodiestarase 4D alters airway smooth muscle cell phenotypes",
abstract = "Airway hyperresponsiveness (AHR) is a hallmark feature in asthma characterized by exaggerated airway contractile response to stimuli due to increased airway sensitivity and chronic airway remodeling. We have previously shown that allergen-induced AHR in mice is associated with aberrant DNA methylation in the lung genome, suggesting that AHR could be epigenetically regulated, and these changes might predispose the animals to asthma. Previous studies demonstrated that overexpression of phosphodiesterase 4D (PDE4D) is associated with increased AHR. However, epigenetic regulation of this gene in asthmatic airway smooth muscle cells (ASMCs) has not been examined. In this study, we aimed to examine the relationship between epigenetic regulation of PDE4D and ASMC phenotypes. We identified CpG site-specific hypomethylation at PDE4D promoter in human asthmatic ASMCs. We next used methylated oligonucleotides to introduce CpG site-specific methylation at PDE4D promoter and examined its effect on ASMCs. We showed that PDE4D methylation decreased cell proliferation and migration of asthmatic ASMCs. We further elucidated that methylated PDE4D decreased PDE4D expression in asthmatic ASMCs, increased cAMP level, and inhibited the aberrant increase in Ca2+ level. Moreover, PDE4D methylation reduced the phosphorylation level of downstream effectors of Ca signaling, including myosin light chain kinase and p38. Taken together, our findings demonstrate that gene-specific epigenetic changes may predispose ASMCs to asthma through alterations in cell phenotypes. Modulation of ASMC phenotypes by methylated PDE4D oligonucleotides can reverse the aberrant ASMC functions to normal phenotypes. This has provided new insight to the development of novel therapeutic options for this debilitative disease.",
keywords = "Airway hyperresponsiveness, Airway smooth muscle cell, DNA methylation, Methylated DNA oligonucleotides, Phosphodiesterase 4D",
author = "Lin, {Amanda H Y} and Yan Shang and Mitzner, {Wayne A} and James Sham and Wan-Yee Tang",
year = "2016",
month = "2",
day = "1",
doi = "10.1165/rcmb.2015-0079OC",
language = "English (US)",
volume = "54",
pages = "241--249",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Aberrant DNA methylation of phosphodiestarase 4D alters airway smooth muscle cell phenotypes

AU - Lin, Amanda H Y

AU - Shang, Yan

AU - Mitzner, Wayne A

AU - Sham, James

AU - Tang, Wan-Yee

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Airway hyperresponsiveness (AHR) is a hallmark feature in asthma characterized by exaggerated airway contractile response to stimuli due to increased airway sensitivity and chronic airway remodeling. We have previously shown that allergen-induced AHR in mice is associated with aberrant DNA methylation in the lung genome, suggesting that AHR could be epigenetically regulated, and these changes might predispose the animals to asthma. Previous studies demonstrated that overexpression of phosphodiesterase 4D (PDE4D) is associated with increased AHR. However, epigenetic regulation of this gene in asthmatic airway smooth muscle cells (ASMCs) has not been examined. In this study, we aimed to examine the relationship between epigenetic regulation of PDE4D and ASMC phenotypes. We identified CpG site-specific hypomethylation at PDE4D promoter in human asthmatic ASMCs. We next used methylated oligonucleotides to introduce CpG site-specific methylation at PDE4D promoter and examined its effect on ASMCs. We showed that PDE4D methylation decreased cell proliferation and migration of asthmatic ASMCs. We further elucidated that methylated PDE4D decreased PDE4D expression in asthmatic ASMCs, increased cAMP level, and inhibited the aberrant increase in Ca2+ level. Moreover, PDE4D methylation reduced the phosphorylation level of downstream effectors of Ca signaling, including myosin light chain kinase and p38. Taken together, our findings demonstrate that gene-specific epigenetic changes may predispose ASMCs to asthma through alterations in cell phenotypes. Modulation of ASMC phenotypes by methylated PDE4D oligonucleotides can reverse the aberrant ASMC functions to normal phenotypes. This has provided new insight to the development of novel therapeutic options for this debilitative disease.

AB - Airway hyperresponsiveness (AHR) is a hallmark feature in asthma characterized by exaggerated airway contractile response to stimuli due to increased airway sensitivity and chronic airway remodeling. We have previously shown that allergen-induced AHR in mice is associated with aberrant DNA methylation in the lung genome, suggesting that AHR could be epigenetically regulated, and these changes might predispose the animals to asthma. Previous studies demonstrated that overexpression of phosphodiesterase 4D (PDE4D) is associated with increased AHR. However, epigenetic regulation of this gene in asthmatic airway smooth muscle cells (ASMCs) has not been examined. In this study, we aimed to examine the relationship between epigenetic regulation of PDE4D and ASMC phenotypes. We identified CpG site-specific hypomethylation at PDE4D promoter in human asthmatic ASMCs. We next used methylated oligonucleotides to introduce CpG site-specific methylation at PDE4D promoter and examined its effect on ASMCs. We showed that PDE4D methylation decreased cell proliferation and migration of asthmatic ASMCs. We further elucidated that methylated PDE4D decreased PDE4D expression in asthmatic ASMCs, increased cAMP level, and inhibited the aberrant increase in Ca2+ level. Moreover, PDE4D methylation reduced the phosphorylation level of downstream effectors of Ca signaling, including myosin light chain kinase and p38. Taken together, our findings demonstrate that gene-specific epigenetic changes may predispose ASMCs to asthma through alterations in cell phenotypes. Modulation of ASMC phenotypes by methylated PDE4D oligonucleotides can reverse the aberrant ASMC functions to normal phenotypes. This has provided new insight to the development of novel therapeutic options for this debilitative disease.

KW - Airway hyperresponsiveness

KW - Airway smooth muscle cell

KW - DNA methylation

KW - Methylated DNA oligonucleotides

KW - Phosphodiesterase 4D

UR - http://www.scopus.com/inward/record.url?scp=84963818071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963818071&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2015-0079OC

DO - 10.1165/rcmb.2015-0079OC

M3 - Article

C2 - 26181301

AN - SCOPUS:84963818071

VL - 54

SP - 241

EP - 249

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -